BioVex to Report Phase II Clinical Trial Results of OncoVEX GM-CSF in - PR Newswire
May 17th, 2008 by admin
Lentigen Corporation Receives Four Research Grants From the National - Forbes
BALTIMORE, May 15 /PRNewswire/ — Lentigen Corporation announced today that it has received four National Institutes of Health (NIH) small business innovation research (SBIR) grants to collaborate with leading scientists. Through these grants
Source: www.forbes.com
Novel double therapy against melanoma - Science Centric
By targeting and disabling a protein frequently found in melanoma tumours, doctors may be able to make the cancer more vulnerable to chemotherapy, according to a new study by researchers in the Duke Comprehensive Cancer Centre. ‘We tested a compound
Source: www.sciencecentric.com
Skin: Applying a Balm to the Years - New York Times
KEEPING skin healthy as decades pass can be as easy as remembering this adage: Accept the things you cannot change. Have the courage to change the things you can. Be wise enough to tell the difference. Ah, that is the hard part. When $89 anti-aging
Source: www.nytimes.com
Only 1 in 20 cancer survivors meet diet advice - MSNBC
Just 5 percent of U.S. cancer survivors are meeting experts’ recommendations on diet, physical activity and cigarette smoking, a new survey shows. But the more recommendations a cancer survivor did meet, the better his or her health-related quality
Source: www.msnbc.msn.com